| Ytd | -15.77% | |
| 1y | -14.45% |
| Open | 2.15 | Prev Close | 2.18 | Low | 2.15 | High | 2.15 | Mkt Cap | 17.66M |
| Vol | 1.60K | Avg Vol | 35.82K | EPS | -1.92 | P/E | -1.14 | Forward P/E | 3.57 |
| Beta | 0.24 | Short Ratio | 10.45 | Inst. Own | 34.04% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-14 | 50-d Avg | 2.20 | 200-d Avg | 2.37 | 1yr Est | 8.00 |
AYTU News
ACR, AEM and AYTU have been added to the Zacks Rank #5 (Strong Sell) List on July 20, 2026.
AYTU, CAMP and CRC have been added to the Zacks Rank #5 (Strong Sell) List on July 16, 2026.
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001385818/000143774926021707/aytu20260624c_8k.htm
DENVER, CO / ACCESS Newswire / June 1, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq
DENVER, CO / ACCESS Newswire / May 18, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq
Aytu BioPharma, Inc. (AYTU) Q3 2026 Earnings Call Transcript
Aytu BioPharma, Inc. (AYTU) came out with a quarterly loss of $0.53 per share versus the Zacks Conse
EXXUA -- with only a partial quarter of full sales force support -- contributed $2.4 million in net
DENVER, CO / ACCESS Newswire / May 6, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:
Shares of Aytu BioPharma Inc. (NASDAQ: AYTU - Get Free Report) have received a consensus rating of "
Aytu BioPharma, Inc. (AYTU) Q2 2026 Earnings Call Transcript
Aytu BioPharma Inc. (AYTU) came out with a quarterly loss of $1.05 per share versus the Zacks Consen
Total net revenue of $15.2 million Adjusted EBITDA1 of $(0.8) million, which includes EXXUA launch i
AAWH, AYTU and BCAL have been added to the Zacks Rank #5 (Strong Sell) List on February 2, 2026.
DENVER, CO / ACCESS Newswire / January 27, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Na
Shares of Aytu BioPharma Inc. (NASDAQ: AYTU - Get Free Report) have been assigned a consensus recomm
Aytu BioPharma, Inc. (AYTU) Analyst/Investor Day Transcript
DENVER, CO / ACCESS Newswire / January 20, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Na
DENVER, CO / ACCESS Newswire / January 13, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Na
DENVER, CO / ACCESS Newswire / January 12, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Na
Aytu BioPharma Inc. (NASDAQ: AYTU - Get Free Report) has been given a consensus recommendation of "H
On Friday morning, 446 companies hit new 52-week lows.
On Tuesday, 250 stocks hit new 52-week lows.
On Friday, 1043 companies hit new 52-week lows.
On Friday, 431 companies hit new 52-week lows.
Stocks That Hit 52-Week Lows On Thursday
Stocks Which Set New 52-Week Low Yesterday, October 11th
Stocks Which Set New 52-Week Low Yesterday, October 10th
Stocks Which Set New 52-Week Low Yesterday, October 9th
Stocks Which Set New 52-Week Low Friday, October 5th